USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Amolifescience Co., Ltd.

USPTO PatentsView assignee record - 28 granted patents across 41 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Amolifescience ranks #10,847 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 41 technology areas.

#10,847
of 49,997 US assignees by volume
Top 14%
by Innovation Score (50.0/100)
10.2
avg claims per patent
+425%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10847 · Foreign Corporation #10,847 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 28 grants
  • UPPER-Q #10,847/49,997
  • PHOTO-FINISH Acutus Medical
  • CPC-WIDE A61K · 41 areas
  • INNOV-PAR 50.0/100
  • CLAIMS-PAR 10.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +425% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acutus Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Amolifescience’s 50.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Amolifescience

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Amolifescience's Innovation Score is 50.0/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Amolifescience?

Each dot is one of Amolifescience’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amolifescience’s own 10.2 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Amolifescience vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 27.92828.1 0510152025 Granted patents (volume) Avg claims / patent Acutus Medical, Inc. - 28, 22.32Acutus MedicalAdvanced Technology Emission Solutions Inc. - 28, 15.39Advanced Technolo…Alipay Labs (SINGAPORE) PTE. Ltd. - 28, 20.54Alipay Labs (Sing…Allbirds, Inc. - 28, 4.32AllbirdsAnavex Life Sciences Corp. - 28, 14.82Anavex Life Scien…Anji Hengjian Smart Home Technology Co., Ltd. - 28, 1.43Anji Hengjian Sma…Applejack 199 L.P. - 28, 16.79Applejack 199Arizona Board OF Regents, Acting FOR AND ON Behalf OF Arizona State University - 28, 15.43Arizona Board OF…Amolifescience Co., Ltd. - 28, 10.21Amolifescience
Amolifescience vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Amolifescience's grants concentrate

Amolifescience Co., Ltd. is a focused PatentsView assignee: 41 CPC subclasses with 35.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2019. By volume, Amolifescience sits between Acutus Medical, Inc. and Arizona Board OF Regents, Acting FOR AND ON Behalf OF Arizona State University.

Amolifescience's three-year grant acceleration

Amolifescience Co., Ltd. shows 13 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Amolifescience's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Amolifescience holds 28 patents at rank #10,841, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Amolifescience

By rank, the assignees closest to #10,841 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Amolifescience's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Amolifescience, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Amolifescience ranks #2,196 of 7,163 assignees by patent count in that subclass.

Amolifescience's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20182019202020212022202320242025 3
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Amolifescience Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 3 10.7%
2019 1 3.6%
2020 5 17.9%
2021 3 10.7%
2022 5 17.9%
2023 4 14.3%
2024 4 14.3%
2025partial year 3 10.7%

Which technologies does Amolifescience Co., Ltd. patent most?

Top 15 of 41 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Amolifescience Co., Ltd.'s patent record in context - here's where to go next.

  • Amolifescience Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 35.7% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #10,847 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Amolifescience Co., Ltd. against Acutus Medical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 50.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.